{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T22:41:12Z","timestamp":1788388872281,"version":"build-2803163510"},"reference-count":46,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,2,25]],"date-time":"2023-02-25T00:00:00Z","timestamp":1677283200000},"content-version":"am","delay-in-days":361,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1016\/j.vaccine.2021.01.025","type":"journal-article","created":{"date-parts":[[2021,1,25]],"date-time":"2021-01-25T08:40:49Z","timestamp":1611564049000},"page":"1555-1562","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Live attenuated Bordetella pertussis vaccine candidate BPZE1 transiently protects against lethal pneumococcal disease in mice"],"prefix":"10.1016","volume":"40","author":[{"given":"Thomas","family":"Belcher","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hana","family":"Kammoun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lo\u00efc","family":"Coutte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Sophie","family":"Debrie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Mielcarek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Claude","family":"Sirard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e9phane","family":"Cauchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camille","family":"Locht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.vaccine.2021.01.025_b0005","doi-asserted-by":"crossref","first-page":"e65","DOI":"10.1371\/journal.ppat.0020065","article-title":"Live attenuated B. pertussis as a single-dose nasal vaccine against whooping cough","volume":"2","author":"Mielcarek","year":"2006","journal-title":"PLoS Pathog"},{"issue":"9","key":"10.1016\/j.vaccine.2021.01.025_b0010","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1016\/S1473-3099(17)30390-0","article-title":"An update of the global burden of pertussis in children younger than 5 years: a modelling study","volume":"17","author":"Yeung","year":"2017","journal-title":"Lancet Infect Dis"},{"issue":"43","key":"10.1016\/j.vaccine.2021.01.025_b0015","doi-asserted-by":"crossref","first-page":"7047","DOI":"10.1016\/j.vaccine.2010.08.017","article-title":"Long-term immunity against pertussis induced by a single nasal administration of live attenuated B. pertussis BPZE1","volume":"28","author":"Feunou","year":"2010","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2021.01.025_b0020","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1128\/CVI.00371-10","article-title":"A live, attenuated Bordetella pertussis vaccine provides long-term protection against virulent challenge in a murine model","volume":"18","author":"Skerry","year":"2011","journal-title":"Clin Vaccine Immunol"},{"issue":"6","key":"10.1016\/j.vaccine.2021.01.025_b0025","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1038\/s41385-018-0073-9","article-title":"IL-17-dependent SIgA-mediated protection against nasal Bordetella pertussis infection by live attenuated BPZE1 vaccine","volume":"11","author":"Solans","year":"2018","journal-title":"Mucosal Immunol"},{"issue":"1","key":"10.1016\/j.vaccine.2021.01.025_b0030","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1093\/infdis\/jix254","article-title":"Live attenuated pertussis vaccine BPZE1 protects baboons against Bordetella pertussis disease and infection","volume":"216","author":"Locht","year":"2017","journal-title":"J Infect Dis"},{"issue":"1","key":"10.1016\/j.vaccine.2021.01.025_b0035","doi-asserted-by":"crossref","first-page":"e83449","DOI":"10.1371\/journal.pone.0083449","article-title":"A phase I clinical study of a live attenuated Bordetella pertussis vaccine\u2013BPZE1; a single centre, double-blind, placebo-controlled, dose-escalating study of BPZE1 given intranasally to healthy adult male volunteers","volume":"9","author":"Thorstensson","year":"2014","journal-title":"PLoS ONE"},{"issue":"11","key":"10.1016\/j.vaccine.2021.01.025_b0040","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1016\/S1473-3099(20)30274-7","article-title":"Safety and immunogenicity of the live attenuated intranasal pertussis vaccine BPZE1: a phase 1b, double-blind, randomised, placebo-controlled dose-escalation study","volume":"20","author":"Jahnmatz","year":"2020","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2021.01.025_b0045","doi-asserted-by":"crossref","first-page":"2872","DOI":"10.3389\/fimmu.2018.02872","article-title":"Non-specific effects of live attenuated pertussis vaccine against heterologous infectious and inflammatory diseases","volume":"9","author":"Cauchi","year":"2018","journal-title":"Front Immunol"},{"issue":"14","key":"10.1016\/j.vaccine.2021.01.025_b0050","doi-asserted-by":"crossref","first-page":"7105","DOI":"10.1128\/JVI.02542-09","article-title":"Attenuated Bordetella pertussis protects against highly pathogenic influenza A viruses by dampening the cytokine storm","volume":"84","author":"Li","year":"2010","journal-title":"J Virol"},{"issue":"2","key":"10.1016\/j.vaccine.2021.01.025_b0055","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1164\/rccm.201307-1227OC","article-title":"Attenuated Bordetella pertussis vaccine protects against respiratory syncytial virus disease via an IL-17-dependent mechanism","volume":"189","author":"Schnoeller","year":"2014","journal-title":"Am J Respir Crit Care Med"},{"issue":"6","key":"10.1016\/j.vaccine.2021.01.025_b0060","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1111\/j.1365-2222.2010.03459.x","article-title":"Attenuated Bordetella pertussis vaccine strain BPZE1 modulates allergen-induced immunity and prevents allergic pulmonary pathology in a murine model","volume":"40","author":"Kavanagh","year":"2010","journal-title":"Clin Exp Allergy"},{"issue":"10","key":"10.1016\/j.vaccine.2021.01.025_b0065","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1111\/j.1398-9995.2012.02884.x","article-title":"Attenuated Bordetella pertussis BPZE1 protects against allergic airway inflammation and contact dermatitis in mouse models","volume":"67","author":"Li","year":"2012","journal-title":"Allergy"},{"issue":"9693","key":"10.1016\/j.vaccine.2021.01.025_b0070","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/S0140-6736(09)61204-6","article-title":"Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates","volume":"374","author":"O'Brien","year":"2009","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.vaccine.2021.01.025_b0075","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1086\/381547","article-title":"Nasopharyngeal carriage of Streptococcus pneumoniae by adults and children in community and family settings","volume":"38","author":"Regev-Yochay","year":"2004","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.vaccine.2021.01.025_b0080","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1099\/jmm.0.47470-0","article-title":"Prevalence and risk factors for nasopharyngeal carriage of Streptococcus pneumoniae among adolescents","volume":"57","author":"Cardozo","year":"2008","journal-title":"J Med Microbiol"},{"key":"10.1016\/j.vaccine.2021.01.025_b0085","doi-asserted-by":"crossref","first-page":"34888","DOI":"10.1038\/srep34888","article-title":"Molecular surveillance on Streptococcus pneumoniae carriage in non-elderly adults; little evidence for pneumococcal circulation independent from the reservoir in children","volume":"6","author":"Wyllie","year":"2016","journal-title":"Sci Rep"},{"issue":"3","key":"10.1016\/j.vaccine.2021.01.025_b0090","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1053\/jinf.2000.0653","article-title":"Early predictors of mortality in pneumococcal bacteraemia","volume":"40","author":"Balakrishnan","year":"2000","journal-title":"J Infect"},{"issue":"3","key":"10.1016\/j.vaccine.2021.01.025_b0095","doi-asserted-by":"crossref","first-page":"e31","DOI":"10.1371\/journal.pgen.0020031","article-title":"Genetic analysis of the capsular biosynthetic locus from all 90 pneumococcal serotypes","volume":"2","author":"Bentley","year":"2006","journal-title":"PLoS Genet"},{"issue":"2","key":"10.1016\/j.vaccine.2021.01.025_b0100","doi-asserted-by":"crossref","DOI":"10.1128\/microbiolspec.GPP3-0004-2018","article-title":"Streptococcus pneumoniae: Invasion and Inflammation","volume":"7","author":"Loughran","year":"2019","journal-title":"Microbiol Spectr"},{"issue":"6","key":"10.1016\/j.vaccine.2021.01.025_b0105","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1513\/AnnalsATS.201511-778FR","article-title":"Pneumococcal vaccination strategies. An update and perspective","volume":"13","author":"Berical","year":"2016","journal-title":"Ann Am Thorac Soc"},{"issue":"1","key":"10.1016\/j.vaccine.2021.01.025_b0110","doi-asserted-by":"crossref","first-page":"13","DOI":"10.3390\/vaccines7010013","article-title":"The role of serotype-specific immunological memory in pneumococcal vaccination: current knowledge and future prospects","volume":"7","author":"Papadatou","year":"2019","journal-title":"Vaccines"},{"issue":"9","key":"10.1016\/j.vaccine.2021.01.025_b0115","doi-asserted-by":"crossref","first-page":"e1001517","DOI":"10.1371\/journal.pmed.1001517","article-title":"Serotype-specific changes in invasive pneumococcal disease after pneumococcal conjugate vaccine introduction: a pooled analysis of multiple surveillance sites","volume":"10","author":"Feikin","year":"2013","journal-title":"PLoS Med"},{"issue":"9807","key":"10.1016\/j.vaccine.2021.01.025_b0120","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1016\/S0140-6736(10)62225-8","article-title":"Serotype replacement in disease after pneumococcal vaccination","volume":"378","author":"Weinberger","year":"2011","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.vaccine.2021.01.025_b0125","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1080\/14760584.2018.1413354","article-title":"Public health impact of pneumococcal conjugate vaccine infant immunization programs: assessment of invasive pneumococcal disease burden and serotype distribution","volume":"17","author":"Izurieta","year":"2018","journal-title":"Expert Rev Vaccines"},{"issue":"3","key":"10.1016\/j.vaccine.2021.01.025_b0130","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1128\/CMR.00058-15","article-title":"Biological and epidemiological features of antibiotic-resistant Streptococcus pneumoniae in pre- and post-conjugate vaccine eras: a United States perspective","volume":"29","author":"Kim","year":"2016","journal-title":"Clin Microbiol Rev"},{"issue":"5","key":"10.1016\/j.vaccine.2021.01.025_b0135","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1111\/j.1469-0691.2010.03182.x","article-title":"Changes in antimicrobial resistance, serotypes and genotypes in Streptococcus pneumoniae over a 30-year period","volume":"16","author":"Li\u00f1ares","year":"2010","journal-title":"Clin Microbiol Infect"},{"issue":"3","key":"10.1016\/j.vaccine.2021.01.025_b0140","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1128\/iai.41.3.1138-1143.1983","article-title":"Effect of heptakis (2,6-O-dimethyl) beta-cyclodextrin on the production of pertussis toxin by Bordetella pertussis","volume":"41","author":"Imaizumi","year":"1983","journal-title":"Infect Immun"},{"issue":"34","key":"10.1016\/j.vaccine.2021.01.025_b0145","doi-asserted-by":"crossref","first-page":"3923","DOI":"10.1016\/j.vaccine.2016.06.020","article-title":"Heterologous vaccine effects","volume":"34","author":"Saadatian-Elahi","year":"2016","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.vaccine.2021.01.025_b0150","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1007\/s12026-017-8957-4","article-title":"Differences in innate IFN\u03b3 and IL-17 responses to Bordetella pertussis between BALB\/c and C57BL\/6 mice: role of \u03b3\u03b4T cells, NK cells, and dendritic cells","volume":"65","author":"Mosley","year":"2017","journal-title":"Immunol Res"},{"issue":"1","key":"10.1016\/j.vaccine.2021.01.025_b0155","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/nri3777","article-title":"Epigenetic control of myeloid cell differentiation, identity and function","volume":"15","author":"\u00c1lvarez-Errico","year":"2015","journal-title":"Nat Rev Immunol"},{"issue":"7","key":"10.1016\/j.vaccine.2021.01.025_b0160","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1038\/ni.3178","article-title":"Innate immune memory: a paradigm shift in understanding host defense","volume":"16","author":"Netea","year":"2015","journal-title":"Nat Immunol"},{"key":"10.1016\/j.vaccine.2021.01.025_b0165","doi-asserted-by":"crossref","first-page":"79","DOI":"10.3389\/fpubh.2018.00079","article-title":"Evidence of increase in mortality after the introduction of diphtheria-tetanus-pertussis vaccine to children aged 6\u201335 months in Guinea-Bissau: a time for reflection?","volume":"6","author":"Aaby","year":"2018","journal-title":"Front Public Health"},{"issue":"7","key":"10.1016\/j.vaccine.2021.01.025_b0170","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/14760584.2017.1333906","article-title":"BCG and protection against inflammatory and auto-immune diseases","volume":"16","author":"Kowalewicz-Kulbat","year":"2017","journal-title":"Expert Rev Vaccines"},{"issue":"4","key":"10.1016\/j.vaccine.2021.01.025_b0175","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1189\/jlb.3A0315-101R","article-title":"Unconventional, adenosine-producing suppressor T cells induced by dendritic cells exposed to BPZE1 pertussis vaccine","volume":"98","author":"Fedele","year":"2015","journal-title":"J Leukoc Biol"},{"issue":"12","key":"10.1016\/j.vaccine.2021.01.025_b0180","doi-asserted-by":"crossref","first-page":"3293","DOI":"10.4049\/jimmunol.1901102","article-title":"Early protection against pertussis induced by live attenuated Bordetella pertussis BPZE1 depends on TLR4","volume":"203","author":"Debrie","year":"2019","journal-title":"J Immunol"},{"issue":"12","key":"10.1016\/j.vaccine.2021.01.025_b0185","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1164\/rccm.200607-1038OC","article-title":"Stimulation of lung innate immunity protects against lethal pneumococcal pneumonia in mice","volume":"177","author":"Clement","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"10.1016\/j.vaccine.2021.01.025_b0190","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1165\/rcmb.2008-0260OC","article-title":"Stimulated innate resistance of lung epithelium protects mice broadly against bacteria and fungi","volume":"42","author":"Evans","year":"2010","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.vaccine.2021.01.025_b0195","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1146\/annurev-physiol-021909-135909","article-title":"Inducible innate resistance of lung epithelium to infection","volume":"72","author":"Evans","year":"2010","journal-title":"Annu Rev Physiol"},{"issue":"1","key":"10.1016\/j.vaccine.2021.01.025_b0200","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1111\/j.1476-5381.2011.01237.x","article-title":"Inhaled innate immune ligands to prevent pneumonia","volume":"163","author":"Evans","year":"2011","journal-title":"Br J Pharmacol"},{"issue":"10","key":"10.1016\/j.vaccine.2021.01.025_b0205","doi-asserted-by":"crossref","first-page":"4226","DOI":"10.1128\/IAI.00224-10","article-title":"Mucosal administration of flagellin protects mice from Streptococcus pneumoniae lung infection","volume":"78","author":"Munoz","year":"2010","journal-title":"Infect Immun"},{"issue":"3","key":"10.1016\/j.vaccine.2021.01.025_b0210","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1128\/IAI.67.3.1056-1062.1999","article-title":"Role of Bordetella pertussis virulence factors in adherence to epithelial cell lines derived from the human respiratory tract","volume":"67","author":"van den Berg","year":"1999","journal-title":"Infect Immun"},{"issue":"1","key":"10.1016\/j.vaccine.2021.01.025_b0215","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/j.1574-695X.2005.00001.x","article-title":"Bordetella pertussis attachment to respiratory epithelial cells can be impaired by fimbriae-specific antibodies","volume":"46","author":"Rodr\u00edguez","year":"2006","journal-title":"FEMS Immunol Med Microbiol"},{"issue":"2","key":"10.1016\/j.vaccine.2021.01.025_b0220","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1111\/j.1574-695X.2009.00557.x","article-title":"Cholesterol-dependent attachment of human respiratory cells by Bordetella pertussis","volume":"56","author":"Lamberti","year":"2009","journal-title":"FEMS Immunol Med Microbiol"},{"issue":"3","key":"10.1016\/j.vaccine.2021.01.025_b0225","doi-asserted-by":"crossref","first-page":"177","DOI":"10.3109\/23744235.2015.1100323","article-title":"Highly differentiated human airway epithelial cells: a model to study host cell-parasite interactions in pertussis","volume":"48","author":"Guevara","year":"2016","journal-title":"Infect Dis"},{"issue":"25","key":"10.1016\/j.vaccine.2021.01.025_b0230","doi-asserted-by":"crossref","first-page":"13847","DOI":"10.1073\/pnas.230262797","article-title":"The transcriptional responses of respiratory epithelial cells to Bordetella pertussis reveal host defensive and pathogen counter-defensive strategies","volume":"97","author":"Belcher","year":"2000","journal-title":"Proc Natl Acad Sci U S A"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X21000414?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X21000414?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T11:08:37Z","timestamp":1759403317000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X21000414"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":46,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["S0264410X21000414"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2021.01.025","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Live attenuated Bordetella pertussis vaccine candidate BPZE1 transiently protects against lethal pneumococcal disease in mice","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2021.01.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}